Debra M. Bensen-Kennedy

Author

Also Known As

D. Bensen-Kennedy, D. Bensen‐Kennedy, Debra Bensen-Kennedy, Debra Bensen‐Kennedy, Debra M Bensen-Kennedy, Debra M. Bensen-Kennedy

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University University of Pennsylvania CSL (United States)Behringwerke (Germany)Cornell University

About

Debra M. Bensen-Kennedy is an author at Johns Hopkins University specializing in medicine, pediatrics, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	111
2	Pharmacology	1	1	13
3	Clinical Trials	1	1	13
4	Neuro-oncology	1	1	98
5	Glioma	1	1	98

Debra M. Bensen-Kennedy

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse Mark J. Levis, Farhad Ravandi, Eunice S. Wang, Blood	2011	395
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor Hilary Longhurst, Marco Cicardi, Timothy Craig, New England Journal of Medicine	2017	219
Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs Karen E. King, R. Sue Shirey, Sandra K. Thoman, Transfusion	2004	213
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study Jane E. Minturn, Audrey E. Evans, Judith G. Villablanca, Cancer Chemotherapy and Pharmacology Neuro-oncologyPediatric NeurosurgeryRefractory NeuroblastomaPediatricsNew Approaches	2011	98
Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A Johnny Mahlangu, Kazimierz Kuliczkowski, Faraizah Abdul Karim, Blood	2016	85
First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse B. Douglas Smith, Gail J. Roboz, Roland B. Walter, Blood	2014	60
Comparative pharmacokinetics of <scp>rVIII</scp>‐SingleChain and octocog alfa (Advate<sup>®</sup>) in patients with severe haemophilia A Robert Klamroth, Mindy Simpson, M. von Depka‐Prondzinski, Haemophilia	2016	56
Safety and pharmacokinetics of a recombinant fusion protein linking coagulation factor VIIa with albumin in healthy volunteers Georg Golor, Debra M. Bensen-Kennedy, Steven M. Haffner, Journal of Thrombosis and Haemostasis	2013	40
An Open-Label Study of CEP-701 in Patients with JAK2 V617F-Positive PV and ET: Update of 39 Enrolled Patients. Alison R. Moliterno, Elizabeth O. Hexner, Gail J. Roboz, Blood	2009	40
International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories Katie St. Ledger, Annette Feussner, Uwe Kalina, Journal of Thrombosis and Haemostasis	2017	38

Page 1